Cargando…
Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines
Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approxim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004877/ https://www.ncbi.nlm.nih.gov/pubmed/33807062 http://dx.doi.org/10.3390/pharmaceutics13030434 |
_version_ | 1783672004030758912 |
---|---|
author | Samson, Kerr D. G. Bolle, Eleonore C. L. Sarwat, Mariah Dargaville, Tim R. Melchels, Ferry P. W. |
author_facet | Samson, Kerr D. G. Bolle, Eleonore C. L. Sarwat, Mariah Dargaville, Tim R. Melchels, Ferry P. W. |
author_sort | Samson, Kerr D. G. |
collection | PubMed |
description | Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approximately 21 days, in a consistent and reproducible manner. The device was constructed out of a flexible poly(ε-caprolactone) photo-cured network fabricated into a hollow tubular shape, which expelled approximately 10% of its total payload within 2 days after bursting. Characterisation of the factors that control the delay of release demonstrated that it was advantageous to adjust material permeability and device wall thickness over manipulation of the osmogent concentration in order to maintain reproducibility in burst delay times. The photo-cured poly(ε-caprolactone) network was shown to be fully degradable in vitro, and there was no evidence of cytotoxicity after 11 days of direct contact with primary dermal fibroblasts. This study provides strong evidence to support further development of flexible biomaterials with the aim of continuing improvement of the device burst characteristics in order to provide the greatest chance of the devices succeeding with in vivo vaccine booster delivery. |
format | Online Article Text |
id | pubmed-8004877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80048772021-03-29 Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines Samson, Kerr D. G. Bolle, Eleonore C. L. Sarwat, Mariah Dargaville, Tim R. Melchels, Ferry P. W. Pharmaceutics Article Single-administration vaccine delivery systems are intended to improve the efficiency and efficacy of immunisation programs in both human and veterinary medicine. In this work, an osmotically triggered delayed delivery device was developed that was able to release a payload after a delay of approximately 21 days, in a consistent and reproducible manner. The device was constructed out of a flexible poly(ε-caprolactone) photo-cured network fabricated into a hollow tubular shape, which expelled approximately 10% of its total payload within 2 days after bursting. Characterisation of the factors that control the delay of release demonstrated that it was advantageous to adjust material permeability and device wall thickness over manipulation of the osmogent concentration in order to maintain reproducibility in burst delay times. The photo-cured poly(ε-caprolactone) network was shown to be fully degradable in vitro, and there was no evidence of cytotoxicity after 11 days of direct contact with primary dermal fibroblasts. This study provides strong evidence to support further development of flexible biomaterials with the aim of continuing improvement of the device burst characteristics in order to provide the greatest chance of the devices succeeding with in vivo vaccine booster delivery. MDPI 2021-03-23 /pmc/articles/PMC8004877/ /pubmed/33807062 http://dx.doi.org/10.3390/pharmaceutics13030434 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Samson, Kerr D. G. Bolle, Eleonore C. L. Sarwat, Mariah Dargaville, Tim R. Melchels, Ferry P. W. Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title | Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title_full | Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title_fullStr | Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title_full_unstemmed | Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title_short | Elastic Bioresorbable Polymeric Capsules for Osmosis-Driven Delayed Burst Delivery of Vaccines |
title_sort | elastic bioresorbable polymeric capsules for osmosis-driven delayed burst delivery of vaccines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004877/ https://www.ncbi.nlm.nih.gov/pubmed/33807062 http://dx.doi.org/10.3390/pharmaceutics13030434 |
work_keys_str_mv | AT samsonkerrdg elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines AT bolleeleonorecl elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines AT sarwatmariah elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines AT dargavilletimr elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines AT melchelsferrypw elasticbioresorbablepolymericcapsulesforosmosisdrivendelayedburstdeliveryofvaccines |